Breaking News Instant updates and real-time market news.

SPWH

Sportsman's Warehouse

$3.46

-0.12 (-3.35%)

, GLOB

Globant

$42.26

-0.64 (-1.49%)

17:32
08/17/17
08/17
17:32
08/17/17
17:32

On The Fly: After Hours Movers

UP AFTER EARNINGS: Sportsman's Warehouse (SPWH), up 15%... Ross Stores (ROST), up 10.9%... Globant (GLOB), up 8.9%... Gap (GPS), up 5.8%... Applied Materials (AMAT), up 3.7%. ALSO HIGHER: Fluidigm (FLDM), up 4.4% after it licensed a CFTR next-generation sequencing assay. LOWER: Senseonics (SENS), down 5.7% after it announced an offering of common stock.

SPWH

Sportsman's Warehouse

$3.46

-0.12 (-3.35%)

GLOB

Globant

$42.26

-0.64 (-1.49%)

ROST

Ross Stores

$53.33

-1.04 (-1.91%)

GPS

Gap

$22.68

0.11 (0.49%)

AMAT

Applied Materials

$43.12

-1.34 (-3.01%)

FLDM

Fluidigm

$3.60

-0.04 (-1.10%)

SENS

Senseonics

$2.44

0.02 (0.83%)

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 21

    Aug

  • 23

    Aug

  • 18

    Aug

SPWH Sportsman's Warehouse
$3.46

-0.12 (-3.35%)

03/26/17
GSCO
03/26/17
DOWNGRADE
Target $6.5
GSCO
Neutral
Sportsman's Warehouse downgraded to Neutral from Buy at Goldman
Goldman Sachs analyst Stephen Tanal downgraded Sportsman's Warehouse to Neutral citing a lack of positive catalysts given the retailer's recent same-store-sales declines. The analyst cut his price target for the shares to $6.50 from $8.50. The stock is down over 50% year-to-date and closed Friday down 39c to $4.64. Tanal sees "some likelihood" that credit and/or liquidity constraints will force Sportsman's to slow its pace of expansion. He sees the stock struggling to move higher until firearm comparisons ease in the fall.
03/24/17
BARD
03/24/17
NO CHANGE
Target $8
BARD
Outperform
Sportsman's Warehouse valuation provides long-term opportunity, says Baird
Baird analyst Peter Benedict noted Sportsman's Warehouse Q4 results were soft and 2017 is expected to be a challenging year but he believes the longer-term risk/reward looks compelling. He cited the company's above average long-term underlying earnings growth prospects. Benedict maintained his Outperform rating and lowered his price target to $8 from $12 on Sportsman's Warehouse shares.
03/24/17
PIPR
03/24/17
DOWNGRADE
Target $4
PIPR
Neutral
Sportsman's Warehouse downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Sportsman's Warehouse to Neutral citing the potential for covenant violations by Q4 or early 2018. Renegotiations of the covenant terms would likely cause a large increase in interest rates, the analyst contends. He cut his price target for the shares to $4 from $10 following Sportsman's Q4 results.
03/15/17
DADA
03/15/17
NO CHANGE
DADA
Sportsman's Warehouse price target lowered to $7 from $11 at DA Davidson
DA Davidson analyst Andrew Burns says that comments from firearms companies suggest that demand for firearms is "softening," but he says that data indicates that the sector is in the midst of " a normal post-surge correction," rather than a tremendous slump. He thinks that Sportsman's Warehouse's balance sheet is "on solid footing entering the downturn," but lowered his estimates for the company slightly to reflect weakening demand. However, he keeps a Buy rating on the shares.
GLOB Globant
$42.26

-0.64 (-1.49%)

07/27/17
RHCO
07/27/17
DOWNGRADE
RHCO
Hold
Globant downgraded on growth outlook, risk, valuation at SunTrust
As noted earlier, SunTrust downgraded Globant to Hold from Buy. As reasons for the downgrade, analyst Frank Atkins cited lack of acceleration of demand, geopolitical risk ahead of Argentina's elections in October, and valuation. Target to $48 from $43.
07/27/17
RHCO
07/27/17
DOWNGRADE
RHCO
Hold
Globant downgraded to Hold from Buy at SunTrust
01/12/17
PACS
01/12/17
UPGRADE
Target $38
PACS
Overweight
Globant upgraded following recent selloff at Pacific Crest
Pacific Crest analyst Arvind Ramnani upgraded Globant to Overweight from Sector Weight saying demand for digital remains strong despite the recent pullback in the shares. Globant, as a pure-play digital company that should sustain 20%-plus growth in the near term, is an "attractive asset to own," Ramnani tells investors in a research note. The analyst has a $38 price target for the shares.
02/21/17
RHCO
02/21/17
NO CHANGE
RHCO
Globant should be bought on any weakness sparked by margins, says SunTrust
SunTrust analyst Frank Atkins says that Globant remains positively differentiated from its peers on several key metrics. He thinks that the company could grow 20%+ over the next three years and recommends buying the shares on any weakness related to worries about near-term margins,. Atkins keeps a Buy rating on the shares.
ROST Ross Stores
$53.33

-1.04 (-1.91%)

08/15/17
WELS
08/15/17
NO CHANGE
WELS
TJX results bode well for off-price sector, says Wells Fargo
Wells Fargo analyst Ike Boruchow says that TJX's (TJX) better than expected Q2 results bode well for the off-price retail sector. The analyst notes that the company's merchandise margins rebounded in Q2, even though its overall gross margins came in below expectations due to "losses on inventory hedges," Other companies in the sector include Ross Stores, (ROST) and Burlington Stores (BURL). The analyst keeps Outperform ratings on all three stocks.
08/02/17
FBCO
08/02/17
NO CHANGE
Target $64
FBCO
Neutral
Ross Stores price target lowered to $64 from $70 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Ross Stores to $64 from $70 given the recent deceleration of returns and widened gap between the off-price group's share price versus the rest of the retail group. The analyst also notes that the company also continues to expand square footage. He reiterates a Neutral rating on the shares.
07/14/17
07/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Boeing (BA) upgraded to Overweight from Neutral at JPMorgan with analyst Seth Seifman saying Boeing is among the stocks best positioned to benefit from positive aerospace fundamentals. 2. Wal-Mart (WMT) and Ulta Beauty (ULTA) were upgraded to Conviction Buy from Neutral at Goldman Sachs. 3. Nutanix (NTNX) upgraded to Conviction Buy, viewed as M&A target at Goldman Sachs with analyst Simona Jankowski saying the company is a "once-in-decade tech infrastructure" that will benefit from double digit growth, high gross margins and significant operating leverage. 4. Ross Stores (ROST) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Dana Telsey saying the company's valuation is attractive and expects focused execution of its off-price model to deliver best everyday value to customers, which should allow it to be a relative share winner. 5. FirstEnergy (FE) upgraded to Hold from Trim at Tudor Pickering. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/17
07/14/17
UPGRADE
Target $70

Outperform
Ross Stores upgraded to Outperform on valuation, execution at Telsey Advisory
As previously reported, Telsey Advisory upgraded Ross Stores to Outperform from Market Perform and maintained a $70 price target. Analyst Dana Telsey thinks Ross' valuation is attractive and expects focused execution of its off-price model to deliver best everyday value to customers, which should allow it to be a relative share winner.
GPS Gap
$22.68

0.11 (0.49%)

07/14/17
JPMS
07/14/17
NO CHANGE
Target $27
JPMS
Neutral
Gap added to Analyst Focus List at JPMorgan
JPMorgan analyst Matthew Boss added Netural-rated Gap to his firm's Analyst Focus List and upped his price target for the shares to $27 from $26. Trading at four times EBITDA with a 4% dividend and 8% free cash flow yield, Gap's near-term risk/reward is "too hard to ignore," Boss tells investors in a research note. He calls the company his top Specialty Softlines idea through the end of 2017.
04/20/17
04/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Starbucks (SBUX) upgraded to Buy from Hold at Stifel with analyst Mark Astrachan saying he views valuation as attractive and expects multiple expansion from accelerating U.S. comparable store sales growth to at least 5%-6% for the next four quarters starting in the June quarter. The analyst said shares have underperformed consumer and restaurant peers over the past 12 months and expects outperformance to be driven by meeting comp expectations. 2. Goldman Sachs (GS) upgraded to Overweight from Neutral at Atlantic Equities with analyst Christopher Wheeler telling investors investors shares are "oversold." The analyst expects the FICC business to bounce back and made just a small reduction in estimates to account for further cost measures. 3. Lear (LEA) upgraded to Outperform from Neutral at Baird with analyst David Leiker citing its recent underperformance despite improving fundamentals and a strong global auto backdrop. Leiker raised his price target to $161 from $160 on Lear shares. 4. Discovery (DISCA) upgraded to Neutral from Sell at Citi with analyst Jason Bazinet saying he sees little chance of material downward revisions to consensus earnings estimates. The analyst views the risk/reward as more balanced at current levels and upped his price target for the shares to $30 from $27. 5. Gap (GPS) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss citing the underperformance of the shares over the past 18 months and his fieldwork which suggests stability at Old Navy. The analyst raised his price target for the shares to $24 from $21. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/05/17
OPCO
06/05/17
UPGRADE
Target $28
OPCO
Outperform
Gap upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Anna Andreeva upgraded Gap to Outperform and raised his price target for the shares to $28 from $24. The shares are down 17% from last month's highs despite the retailer posting 12% earnings growth in Q1, Andreeva tells investors in a research note. Operating primarily off-the-mall, Old Navy continues to benefit from department stores' "malaise," the analyst argues.
06/05/17
06/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Yelp (YELP) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post saying consensus estimates are achievable following the first quarter headline miss. The analyst sees improved quarterly net account adds ahead and improved execution driving shares higher. 2. Exxon Mobil (XOM) upgraded to Outperform from Sector Perform at Scotia Howard Weil with the firm saying recent weakness provides a buying opportunity for this defensive play within the oil patch. 3. eBay (EBAY) upgraded to Outperform from Neutral at Credit Suisse with analyst Paul Bieber assuming coverage on the stock while saying there are multiple paths to create value. 4. Gap (GPS) upgraded to Outperform from Perform at Oppenheimer with analyst Anna Andreeva saying the shares are down 17% from last month's highs despite the retailer posting 12% earnings growth in the first quarter. 5. Outfront Media (OUT) upgraded to Buy from Hold at Loop Capital with analyst David Miller saying he believes the "reward outweighs the risk" with the shares down 17% over the past 15 weeks. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AMAT Applied Materials
$43.12

-1.34 (-3.01%)

07/28/17
CHLM
07/28/17
NO CHANGE
Target $34
CHLM
Buy
Ultra Clean price target raised to $34 from $25 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target on Ultra Clean (UCTT) shares to $34 from $25 after the company reported better than expected results and guidance. If Applied Materials (AMAT), which is a significant Ultra Clean customer, is right with its bullish projections for the WFE market in 2018, Schwab's estimates for Ultra Clean could "prove woefully conservative," he added. The analyst keeps a Buy rating on Ultra Clean shares.
08/14/17
MSCO
08/14/17
NO CHANGE
MSCO
Morgan Stanley remains bullish on Micron, Lam Research and Applied Materials
Morgan Stanley analyst Joseph Moore said he came away from the Flash Memory Summit 2017 with continued conviction on near-term memory fundamentals. The analyst said Micron (MU) expressed "significant" confidence in its 64 layer 3D NAND technology and doesn't see any hurdles to scaling its floating gate 3D NAND process in the near-to-intermediate term. Lam Research (LRCX) increased its NAND industry spending forecast to $70M from $50M over the next 5 years and said it expects memory fundamentals to remain robust in the near-to-intermediate term, Moore said. For Applied Materials (AMAT), the analyst remains positive on the company's transistor formation around 10 nm innovation, TAM expansion around OLED transition, and execution on margin and growth initiatives. Moore said he remains bullish on Micron (MU), Lam Research (LRCX), and Applied Materials (AMAT) and reiterates his Overweight ratings on all.
08/15/17
RBCM
08/15/17
NO CHANGE
RBCM
Applied Materials results should beat expectations, says RBC Capital
RBC Capital analyst Amit Daryanani, predicts that Applied Materials' (AMAT) July quarter results will beat expectations, while its September quarter guidance will also come in above expectations. The analyst says that the company's peer, Lam Research (LRCX), reported "solid" June quarter results and provided September quarter guidance that came in "well above" expectations. The analyst keeps a Sector Perform rating on Applied Materials.
07/11/17
FBCO
07/11/17
NO CHANGE
Target $54
FBCO
Outperform
Applied Materials well positioned for long-term growth, says Credit Suisse
Credit Suisse analyst Farhan Ahmad walked away from a Technology briefing for sell-side investors at Applied Materials' headquarters with greater confidence on the near-term industry outlook, and in the company's ability to outgrow its market segments over the long-term. The analyst continues to believe that market is pricing Applied Materials' secular growth as cyclical, and sees potential for multiple and earnings upside. He reiterates an Outperform rating and $54 price target on the shares.
FLDM Fluidigm
$3.60

-0.04 (-1.10%)

10/13/16
CANT
10/13/16
NO CHANGE
CANT
Fluidigm outlook still positive, says Cantor
After Fludigm reported weaker than expected results, Cantor analyst Bryan Brokmeier is "concerned that the company may be seeing continued weakness in both BioMark and C1 instrument sales," and he thinks that the C1 and Applied businesses may be suffering from low utilization rates. .Brokmeier cut his price target on the stock to $9 from $11, but he continues to believe that the company can obtain a "significant share of the rapidly growing single-cell biology market over the next three to five years." The analyst thinks that the company can turn itself around soon ,and he keeps a Buy rating on the shares.
SENS Senseonics
$2.44

0.02 (0.83%)

12/19/16
12/19/16
UPGRADE
Target $84

Outperform
Dexcom upgraded to Outperform at Oppenheimer
As previously reported, Oppenheimer analyst Steven Lichtman upgraded Dexcom (DXCM) to Outperform from Perform, with an $84 price target, given valuation reflecting competitive concerns and big long-term opportunities in place. While new competition in the U.S. is expected from Medtronic (MDT) and likely Abbott (ABT) and Senseonics (SENS) in 2017, the analyst believes the CGM market remains underpenetrated in Type 1 patients, a dosing claim is expected early 2017, international reimbursement should be a growing tailwind and 2018 brings new growth drivers with expected launch of Dexcom's next-generation G6 and potential Medicare expansion.
06/06/17
LEER
06/06/17
NO CHANGE
Target $6
LEER
Outperform
Senseonics share offering removes overhang, says Leerink
Leerink analyst Danielle Antalffy views Senseonics' recent $41M share offering as a "financially sound move" that removes an overhang. The company's balance sheet is now shored up ahead of the U.S. launch, Antalffy tells investors in a research note. Senseonics' cash position should be sufficient to fund its operations at least through mid-2018, the analyst adds. She views the current valuation levels as an attractive entry point and reiterates an Outperform rating on the shares with a $6 price target.
09/27/16
RILY
09/27/16
INITIATION
Target $5.5
RILY
Buy
Senseonics initiated with a Buy at B. Riley
B. Riley analyst Greg Chodaczek started Senseonics with a Buy rating and $5.50 price target. Eversense is the only long-term, implantable continuous glucose monitoring system, Chodaczek tells investors in a research note.

TODAY'S FREE FLY STORIES

BAC

Bank of America

$24.98

-0.185 (-0.74%)

, CME

CME Group

15:01
09/22/17
09/22
15:01
09/22/17
15:01
Hot Stocks
Bank of America broker-dealer affiliate ordered to pay $2.5M by CFTC »

The U.S. Commodity…

BAC

Bank of America

$24.98

-0.185 (-0.74%)

CME

CME Group

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FCAU

Fiat Chrysler

$17.96

0.59 (3.40%)

15:00
09/22/17
09/22
15:00
09/22/17
15:00
Options
$8.4M call buyer in Fiat Chrysler »

$8.4M call buyer in Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$171.11

-1.06 (-0.62%)

14:53
09/22/17
09/22
14:53
09/22/17
14:53
Periodicals
Facebook settles lawsuit over non-voting shares, Business Insider reports »

Facebook settled a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

XOP

SPDR Oil Exploration and Production Fund

$33.00

0.09 (0.27%)

14:50
09/22/17
09/22
14:50
09/22/17
14:50
Options
SPDR Oil Exploration and Production ETF puts outpace calls 6:1 »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTXI

GTx

$8.74

0.17 (1.98%)

14:48
09/22/17
09/22
14:48
09/22/17
14:48
Conference/Events
GTx, Inc to hold a KOL luncheon meeting »

Management hosts a KOL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.12

0.11 (0.08%)

14:45
09/22/17
09/22
14:45
09/22/17
14:45
Options
Expedia call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$74.21

-7.54 (-9.22%)

14:35
09/22/17
09/22
14:35
09/22/17
14:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.81

-0.13 (-1.31%)

14:27
09/22/17
09/22
14:27
09/22/17
14:27
Hot Stocks
Spectrum lower after Twitter highlights failed trial in Korea »

Shares of Spectrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLPH

Delphi

$102.58

1.54 (1.52%)

14:21
09/22/17
09/22
14:21
09/22/17
14:21
Conference/Events
Delphi to hold investor update meeting »

Investor Update Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

$NSD

NASDAQ Market Internals

14:17
09/22/17
09/22
14:17
09/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/22/17
09/22
14:16
09/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$117.03

0.56 (0.48%)

14:15
09/22/17
09/22
14:15
09/22/17
14:15
Options
Chevron put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 09

    Nov

S

Sprint

$8.42

0.39 (4.86%)

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

14:12
09/22/17
09/22
14:12
09/22/17
14:12
Periodicals
Sprint hired lobbyist tied to Trump in September, Reuters says »

Sprint (S) hired a…

S

Sprint

$8.42

0.39 (4.86%)

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

OPK

OPKO Health

$6.48

0.15 (2.37%)

14:05
09/22/17
09/22
14:05
09/22/17
14:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

14:05
09/22/17
09/22
14:05
09/22/17
14:05
General news
Dallas Fed hawk Kaplan is open minded about one more hike »

Dallas Fed hawk Kaplan is…

GWRE

Guidewire

$78.42

1.26 (1.63%)

14:04
09/22/17
09/22
14:04
09/22/17
14:04
Conference/Events
Guidewire to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

, WPG

Washington Prime

$8.13

0.095 (1.18%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Recommendations
Four Corners Property Trust, Washington Prime analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

WPG

Washington Prime

$8.13

0.095 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

, UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Hot Stocks
Health insurers jump as McCain comes out against latest repeal/replace effort »

Shares of a number of…

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

CNC

Centene

$87.58

-3.16 (-3.48%)

WCG

WellCare

$163.07

-2.99 (-1.80%)

CI

Cigna

$181.14

-0.99 (-0.54%)

ANTM

Anthem

$181.21

-2.29 (-1.25%)

HNT

Health Net

HUM

Humana

$235.79

-2.85 (-1.19%)

AET

Aetna

$150.76

-2.63 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

ICPT

Intercept

$73.70

-24.42 (-24.89%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Downgrade
Intercept rating change  »

Oppenheimer downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$46.29

0.87 (1.92%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Hot Stocks
Trump thanks American Airlines for 'fantastic job' with hurricane flights »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

, RUT

Russell 2000 Index

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

, UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Periodicals
McCain says cannot vote for Graham-Cassidy healthcare bill, Bloomberg reports »

Publicly traded companies…

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

CNC

Centene

$87.61

-3.13 (-3.45%)

WCG

WellCare

$162.70

-3.36 (-2.02%)

CI

Cigna

$181.18

-0.9483 (-0.52%)

ANTM

Anthem

$181.24

-2.26 (-1.23%)

HNT

Health Net

HUM

Humana

$235.91

-2.735 (-1.15%)

AET

Aetna

$150.81

-2.58 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

, XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

13:51
09/22/17
09/22
13:51
09/22/17
13:51
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, the S&P…

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

XLF

Financial Select Sector

$25.43

-0.035 (-0.14%)

XLB

S&P Select Materials SPDR

$56.57

-0.18 (-0.32%)

XLP

Consumer Staples Sector SPDR

$53.97

-0.115 (-0.21%)

XLU

Utilities SPDR

$53.43

-0.24 (-0.45%)

XLV

Health Care Select Sector SPDR

$81.25

-0.33 (-0.40%)

SPY

SPDR S&P 500 ETF Trust

$249.16

-0.23 (-0.09%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.07

0.16 (0.30%)

, UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Periodicals
Total sells Total Italia Gas to UGI Corporation, Reuters reports »

Total (TOT) has sold its…

TOT

Total

$54.07

0.16 (0.30%)

UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.3975 (1.88%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Options
One-week option play opened in Macy's »

One-week option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.